%0 Journal Article
%T 基于缺氧诱导因子通路治疗肾癌的研究进展<br>Research Progress of Treatment of Renal Cell Carcinoma Based on Hypoxia Inducible Factor Pathway
%A 马锦容
%A 靳永胜
%J Advances in Clinical Medicine
%P 353-358
%@ 2161-8720
%D 2024
%I Hans Publishing
%R 10.12677/acm.2024.1461783
%X 肾癌是泌尿系常见恶性肿瘤之一，除外科手术外，其治疗手段包括免疫治疗、靶向治疗、以及细胞疗法等。目前缺氧诱导因子通路治疗肾细胞癌的研究取得了一定的进展，但仍面临许多挑战。本文结合国内外研究报道，针对利用缺氧诱导因子通路治疗肾癌的相关文献进行综述，旨在探讨缺氧诱导因子通路在治疗肾癌研究及应用，以期为探索肾癌治疗提供新的思路，并为肾癌治疗的相关研究提供一定价值。<br />
Renal cell carcinoma (RCC) is one of the most common malignant tumors of the urinary system, in addition to surgery, its treatment includes immunotherapy, targeted therapy, cell therapy and so on. At present, some progress has been made in the treatment of renal cell carcinoma by hypoxia inducible factor pathway, but there are still many challenges. Combined with the research reports at home and abroad, this paper reviews the relevant literature on the treatment of renal cell carcinoma with hypoxia-inducible factor pathway, in order to explore the research and application of hypoxia-inducible factor pathway in the treatment of renal cell carcinoma, in order to provide new ideas for the treatment of renal cell carcinoma, and provide some value for the treatment of renal cell carcinoma.
%K 缺氧诱导因子通路，肾癌，贝组替凡<br>Hypoxia Inducible Factor Pathway
%K Renal Cell Carcinoma
%K Belzutifan
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=89101